Smardii

Smardii

A New Standard of Care for Elderlies

Print
Security Type
Common Stock
Categories
Retail
Min Investment
$250
Location
Miami, FL
Offering Date
August 05, 2021
Expected Close Date
February 01, 2022
Target Raise
$10.00K-$100.00K
Security Price
$3
Valuation
$12,000,000

Company Description

Smardii is a sensor-based wearable solution that transforms any adult incontinence protection into a smart diaper. Our product continuously monitors health conditions, such as the presence and level of urine and stool, the patients’ body positioning for fall detection, and repositioning for pressure ulcers. Smardii is currently in the pre-revenue stage.

Key Deal Facts

Market: long-term care is a trillion-dollar global market, exponentially growing at a cagr of 7.5% (due to baby boomers), and at an accelerated rate since covid-19.
Traction: already 10 long-term care partners signed, plus over $10 million worth of monthly SaaS in our sales funnel (B2B only).
Experienced Team: a very diverse and highly skilled team of scientists, clinicians, and business professionals with over 200 years of combined experience ready to bring this FDA-compliant medical device to the B2B, B2B2C, and B2C markets.

Management Team / Advisory Board Bios

Mathieu Gaddini, Director & Chief Medical Officer
Mathieu has over 20 years of experience as a Medical Doctor and PhD in France. He graduated France premier medicine school (Marseille) with Magna Cum Laude in 2004, where he did his residency between 2000 and 2004, notably in the geriatric and ER pediatric units.
He is a Micronutrient / Morphological Medicine and Anti-Age specialist (MMAA) and is a Medical Expert Witness before the French courts. He is a practicing doctor at many Skilled Nursing Facilities in France, hence has a strong knowledge of medical issues elderlies are experiencing, and operational challenges healthcare operators are facing.
As a practitioner, Mathieu was instrumental in Smardii shift from the original baby-oriented solution to what it has become today, i.e. an adult-focused remote patient monitoring tool.

John Welch, Chief Revenue Officer
John is responsible for Smardii's marketing, sales, and customer engagement activities. He has over 30 years of experience in healthcare and medical products, previously at Dale and Johnson & Johnson, just to name a few. He has a perfect knowledge of the healthcare industry, its various business channels, and helps growing the Smardii brand through customer engagement and strategic partnerships.

Gregory Zaic, Director
MIT and Princeton Engineering graduate, Greg was a general manager at Baxter Labs, responsible for a medical device division. After Baxter, he has spent over 25 years in the life sciences industry. He has served on ~20 boards of directors, several corporate advisory boards and the Columbia University Department of Ophthalmology Board of Advisors. During his career, he has been involved in 7 IPOs and 5 mergers.
Amount Raised : $172,896
Reveal the Score by Voting
_
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter

0 Comments